Indaptus Therapeutics, Inc. (INDP) Stock on an Increasing Trajectory, Here’s Why
Indaptus Therapeutics, Inc. (INDP), a pre-clinical stage biotech company, has surged 17.02% in aftermarket trading session. Consequently, INDP stock is trading at $7.22 at the time of the writing. On Monday, INDP closed the day at $6.17 after soaring 8.25% in regular trading hours. The consistent increase could be attributed to the appointment of a […]
